Stay updated with breaking news from Nyse med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medifast (NYSE:MED – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Monday. Separately, DA Davidson cut their price objective on shares of Medifast from $93.00 to $80.00 and set a “neutral” rating on the stock in a report on […] ....
Rice Hall James & Associates LLC cut its stake in shares of Medifast, Inc. (NYSE:MED – Free Report) by 57.8% in the 1st quarter, Holdings Channel reports. The institutional investor owned 113,468 shares of the specialty retailer’s stock after selling 155,629 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Medifast were […] ....
Medifast (NYSE:MED – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. Separately, DA Davidson lowered their price objective on Medifast from $93.00 to $80.00 and set a “neutral” rating for the company in a research note on […] ....
Medifast, Inc. (NYSE:MED – Get Free Report) Director Jeffrey J. Brown sold 15,154 shares of Medifast stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $92.60, for a total value of $1,403,260.40. Following the sale, the director now directly owns 23,163 shares in the company, valued at […] ....
Medifast (NYSE:MED – Free Report) had its price objective lowered by DA Davidson from $93.00 to $80.00 in a research report released on Tuesday morning, MarketBeat reports. DA Davidson currently has a neutral rating on the specialty retailer’s stock. Separately, StockNews.com raised Medifast from a hold rating to a buy rating in a research report […] ....